Jitka Bařinková

Inhibitor-GCPII Interaction: Selective and Robust System for Targeting Cancer Cells with Structurally Diverse Nanoparticles.

V. Šubr, J. Konvalinka, T. Etrych, 2018, Molecular pharmaceutics.

Rational design of urea-based glutamate carboxypeptidase II (GCPII) inhibitors as versatile tools for specific drug targeting and delivery.

J. Konvalinka, P. Majer, P. Šácha, 2014, Bioorganic & medicinal chemistry.

Label-free determination of prostate specific membrane antigen in human whole blood at nanomolar levels by magnetically assisted surface enhanced Raman spectroscopy.

J. Konvalinka, R. Zbořil, Z. Chaloupková, 2018, Analytica chimica acta.

Design of highly potent urea-based, exosite-binding inhibitors selective for glutamate carboxypeptidase II.

J. Konvalinka, P. Majer, P. Šácha, 2015, Journal of medicinal chemistry.

Design of highly potent urea-based, exosite-binding inhibitors selective for glutamate carboxypeptidase II.

J. Konvalinka, P. Majer, P. Šácha, 2015, Journal of medicinal chemistry.